PETER BARTON HUTT - 09 Jun 2022 Form 4 Insider Report for CONCERT PHARMACEUTICALS, INC.

Role: Director
Signature: /s/ Jeffrey A. Munsie, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 09 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 13 Jun 2022, 16:15:36 UTC
Previous filing: 11 Jun 2021
Next filing: 18 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNCE	Common Stock	Award		+16,400	+125%		29,488	09 Jun 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.
F2	Not applicable.

Content

Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.

Not applicable.